Transcriptional activation of an anti-oxidant mouse Pon2 gene by dexamethasone

BMB Reports

Volumn 42, Issue 7, 2009, Pages 421-426

  Lim, Ji Ae ^a   Kim, Sang Hoon ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR;

ANIMAL; ARTICLE; CELL STRAIN 3T3; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; PROMOTER REGION; TRANSCRIPTION INITIATION;

ANIMALS; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; DEXAMETHASONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOCORTICOIDS; MICE; NIH 3T3 CELLS; PROMOTER REGIONS, GENETIC; RECEPTORS, GLUCOCORTICOID; TRANSCRIPTIONAL ACTIVATION;

EID: 69449101416     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2009.42.7.421     Document Type: Article

References (31)

1. Adcock, I. M. (2000) Molecular mechanisms of glucocorticosteroid actions. Pulm. Pharmacol. Ther. 13, 115-126.
2. Sapolsky, R. M., Romero, L. M. and Munck, A. U. (2000) How do glucocorticoids influence stress response? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Reviews 21, 55-89.
3. Schoneveld, O. J. L. M., Gaemers, I. C. and Lamers, W. H. (2004) Mechanism of glucocorticoid signaling. Biochim. Biophys. Acta 1680, 114-128.
4. Cole, T. J. (2006) Glucocorticoid action and the development of selective glucocorticoid receptor ligands. Biotechnol. Annu. Rev. 12, 269-300.
5. Karin, M. (1998) New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 93, 487-490.
6. Wikström, A-C. (2003) Glucocorticoid action and novel mechanisms of steroid resistance: role of glucocorticoid receptor-interacting proteins for glucocorticoid responsiveness. J. Endoc. 178, 331-337.
7. Adcock, I. M., Ito, K. and Barnes, P. J. (2004) Glucocorticoids: effect on gene transcription. Proc. Am. Thorac. Soc. 1, 247-254.
8. Kurihara, I., Shibata, H., Suzuki, T., Ando, T., Kobayashi, S., Hayashi, M., Saito, I. and Saruta, T. (2002) Expression and regulation of nuclear receptor coactivators in glucocorticoid action. Mol. Cell Endocrinol. 189, 181-189.
9. Heitzer, M. D., Wolf, I. M., Sanchez, E. R., Witchel, S. F. and DeFranco, D. B. (2007) Glucocorticoid receptor physiology. Rev. Endocr. Metab. Disord. 8, 321-330.
10. Robyr, D., Wolffe, A. P. and Wahli, W. (2000) Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol. Endocrinol. 14, 329-347.
11. Acevedo, M. L. and Kraus, W. L. (2004) Transcriptional activiation by nuclear receptors. Essays Biochem. 40, 73-88.
12. Pereira, B., Rosa, L., Safi, D. A., Bechara, E. J. H. and Curi, R. (1995) Hormonal regulation of superoxide dismutase, catalase, and glutathione peroxidase activities in rat macrophases. Biochem. Pharmacol. 50, 2093-2098.
13. José, H. J., Berenice, S-G.A. and Cecilia, V-R. (1997) Induction of antioxidant enzymes by dexamethasone in the adult rat lung. Life Sci. 60, 2059-2067.
14. Melgert, B. N., Olinga, P., Laan, J., Weert, B., Cho, J., Schuppan, D., Groothuis, G., Meijer, D., and Poelstra, K. (2001) Targeting dexamethasone to kupffer cells: effects on liver inflammation and fibrosis in rats. Hepatology 34, 719-728.
15. Ruiz, L. M., Bedoya, G., Sarazar, J., Garcia, O. D. and Patino, P. J. (2002) Dexamethasone inhibits apoptosis of human neutrophils induced by reactive oxygen species. Inflammation 26, 251-262.
16. Rosenblat, M., Draganov, D., Watson, C. E., Bisgaier, C. L., Du, B. N. and Aviram, M. (2003) Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress. Arterioscler. Thromb. Vasc. Biol. 23, 468-474.
17. Ng, C. J., Shih, D. M., Hama, S. Y., Villa, N., Navab, M. and Reddy, S. T. (2005) The paraoxonase gene family and atherosclerosis. Free Radic. Biol. Med. 38, 153-163.
18. Deakin, S. P. and James, R. W. (2008) Transcriptional regulation of the Paraoxonase genes; in The paraoxonases: their role in disease development and xenobiotic metabolism, Mackness, B., Mackness, M., Aviram, M., Paragh, G., (eds.) pp. 241-250, Springer, Berlin.
19. Ng, C. J., Wadleigh, D. J., Gangopadhyay, A., Hama, S., Grijalva, V. R., Navab, M., Fogelman, A. M. and Reddy, S.T. (2001) Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J. Biol. Chem. 30, 44444-44449.
20. Rosenblat, M., Hayek, T., Hussein, K. and Aviram, M. (2004) Decreased macrophage Paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy. Arterioscler. Thromb. Vasc. Biol. 24, 175-180.
21. Horke, S., Witte, I., Wilgenbus, P., Krüger, M., Strand, D. and Förstermann, U. (2007) Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation 115, 2055-2064.
22. Trousson, A., Grenier, J., Fonte, C., Massaad-Massade, L., Schumacher, M. and Massaad, C. (2007) Recruitment of the p160 coactivators by the glucocorticoid receptor: dependence on the promoter context and cell type but not hypoxic conditions. J. Steroid. Biochem. Mol. Biol. 104, 305-311.
23. Fang, H. L., Shenoy, S., Duanmu, Z., Kocarek, T. A. and Morris, M. R. (2003) Transactivation of glucocorticoid-inducible rat aryl sulfotransferase (SULT1A1) gene transcription. Drug. Metab. Disp. 31, 1378-1381.
24. Bian, H. S., Ngo, S. Y. Y., Tan, W., Wong, C. H., Boelsterli, U. A. and Tan, T. M. C. (2007) Induction of human sulfotransferase 1A3 (SULT1A3) by glucocorticoids. Life Sci. 81, 1695-1667.
25. Amat, R., Solanes, G., Giralt, M. and Villarroya, F. (2007) SIRT1 is involved in glucocorticoid-mediated control of uncoupling protein-3 gene transcription. J. Biol. Chem. 282, 34066-34076.
26. Aviram, M. and Rosenblat, M. (2004) Paraoxonase 1, 2 and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic. Biol. Med. 37, 1304-1316.
27. Aviram, M. and Rosenblat, M. (2005) Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. Curr. Opin. Lipidol. 16, 393-399.
28. Shiner, M., Fuhrman, B. and Aviram, M. (2004) Paraoxonase 2 (Pon2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidasedependent mechanism during monocytes differentiation into macrophages. Free Radic. Biol. Med. 37, 2052-2063.
29. Shiner, M., Fuhrman, B. and Aviram, M. (2007) Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR( and AP-1 pathway activation. Atherosclerosis 195, 313-321.
30. Kassel, O. and Herrlich, P. (2007) Crosstalk between the glucocorticoid receptor and other transcription factors: Molecular aspects. Mol. Cell Endocrinology 275, 12-29.
31. Adcock, I. M., Cosio, B., Tsaprouni, L., Barnes, P. J. and Ito, K. (2005) Redox regulation of histone deacetylases and glucocorticoid-mediated inhibition of the inflammatory response. Antioxid. Redox Signal. 7, 144-153.